Genomewide DNA methylation analysis in combat veterans reveals a novel locus 
for PTSD

Mehta, D.; Bruenig, D.; Carrillo-Roa, T.; Lawford, B.; Harvey, W.; Morris, C. P.; Smith, A. K.; Binder, E. B.; Young, R. McD; Voisey, J.

doi:10.1111/acps.12778

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Genomewide DNA methylation analysis in combat veterans reveals a novel locus for PTSD

MPS-Authors

/persons/resource/persons138194

Carrillo-Roa, T.
Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80272

Binder, E. B.
Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;
external;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Mehta, D., Bruenig, D., Carrillo-Roa, T., Lawford, B., Harvey, W., Morris, C. P., et al. (2017). Genomewide DNA methylation analysis in combat veterans reveals a novel locus for PTSD. ACTA PSYCHIATRICA SCANDINAVICA, 136(5), 493-505. doi:10.1111/acps.12778.

Cite as: https://hdl.handle.net/21.11116/0000-0001-BC28-F

Abstract

Objective: Epigenetic modifications such as DNA methylation may play a key role in the aetiology and serve as biomarkers for post-traumatic stress disorder (PTSD). We performed a genomewide analysis to identify genes whose DNA methylation levels are associated with PTSD. Method: A total of 211 individuals comprising Australian male Vietnam War veterans (n = 96) and males from a general population belonging to the Grady Trauma Project (n = 115) were included. Genomewide DNA methylation was performed from peripheral blood using the Illumina arrays. Data analysis was performed using generalized linear regression models. Results: Differential DNA methylation of 17 previously reported PTSD candidate genes was associated with PTSD symptom severity. Genomewide analyses revealed CpG sites spanning BRSK1, LCN8, NFG and DOCK2 genes were associated with PTSD symptom severity. We replicated the findings of DOCK2 in an independent cohort. Pathway analysis revealed that among the associated genes, genes within actin cytoskeleton and focal adhesion molecular pathways were enriched. Conclusion: These data highlight the role of DNA methylation as biomarkers of PTSD. The results support the role of previous candidates and uncover novel genes associated with PTSD, such as DOCK2. This study contributes to our understanding of the biological underpinnings of PTSD.